|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
207,851,000 |
Market
Cap: |
11.39(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$32.18 - $59.82 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Catalent is a holding company. Through its subsidiaries, Co. has two operating and reporting segments: Biologics and Pharma and Consumer Health. The Biologics segment provides development and manufacturing for biologic proteins; cell, gene, and other nucleic acid therapies; plasmid DNA; induced pluripotent stem cells; and vaccines. The Pharma and Consumer Health segment comprises Co.'s capabilities for oral solids, softgel formulations, Zydis® fast-dissolve technologies, and gummy, soft chew, and lozenge dosage forms; formulation, development, and manufacturing platforms for oral, nasal, inhaled, and topical dose forms; and clinical trial development and supply services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
1,000 |
1,000 |
Total Buy Value |
$0 |
$0 |
$49,980 |
$49,980 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
387 |
387 |
11,063 |
116,582 |
Total Sell Value |
$21,749 |
$21,749 |
$512,581 |
$11,151,362 |
Total People Sold |
1 |
1 |
12 |
18 |
Total Sell Transactions |
1 |
1 |
25 |
69 |
End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Fasman Steven L |
SVP & General Counsel |
|
2021-10-04 |
4 |
AS |
$128.56 |
$4,479,975 |
D/D |
(34,714) |
57,133 |
|
-23% |
|
Fasman Steven L |
SVP & General Counsel |
|
2021-10-04 |
4 |
OE |
$36.02 |
$889,050 |
D/D |
17,259 |
91,847 |
|
- |
|
Schmidt Kay A |
SVP, Technical Operations |
|
2021-10-04 |
4 |
AS |
$131.25 |
$287,569 |
D/D |
(2,191) |
13,778 |
|
-23% |
|
Chiminski John R |
Chair & CEO |
|
2021-10-01 |
4 |
AS |
$127.34 |
$19,979,610 |
D/D |
(152,637) |
142,073 |
|
-25% |
|
Chiminski John R |
Chair & CEO |
|
2021-10-01 |
4 |
OE |
$34.91 |
$2,986,973 |
D/D |
75,838 |
294,710 |
|
- |
|
Grippo Michael J |
SVP, Strategy & Corp. Dev. |
|
2021-10-01 |
4 |
AS |
$128.00 |
$270,557 |
D/D |
(2,055) |
12,502 |
|
-25% |
|
Pravda Ricardo |
SVP & Chief HR Officer |
|
2021-10-01 |
4 |
AS |
$132.68 |
$650,928 |
D/D |
(4,906) |
11,747 |
|
-25% |
|
Pravda Ricardo |
SVP & Chief HR Officer |
|
2021-10-01 |
4 |
OE |
$54.94 |
$241,694 |
D/D |
3,818 |
16,653 |
|
- |
|
Chiminski John R |
Chair & CEO |
|
2021-09-01 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,000 |
218,872 |
|
- |
|
Kreuzburg Christa |
Director |
|
2021-08-27 |
4 |
D |
$129.85 |
$25,840 |
D/D |
(199) |
8,566 |
|
- |
|
Gunther Scott |
SVP, Quality & Reg. Affairs |
|
2021-08-27 |
4 |
AS |
$130.29 |
$545,725 |
D/D |
(4,173) |
18,062 |
|
-11% |
|
Chiminski John R |
Chair & CEO |
|
2021-08-27 |
4 |
AS |
$130.41 |
$5,830,711 |
D/D |
(44,488) |
229,872 |
|
-11% |
|
Grippo Michael J |
SVP, Strategy & Corp. Dev. |
|
2021-08-27 |
4 |
AS |
$130.29 |
$222,661 |
D/D |
(1,698) |
14,557 |
|
-11% |
|
Gennadios Aristippos |
President Softgel & Oral Tech |
|
2021-08-27 |
4 |
AS |
$130.29 |
$296,619 |
D/D |
(2,262) |
57,481 |
|
-11% |
|
Castellano Thomas P |
SVP, Chief Financial Officer |
|
2021-08-27 |
4 |
AS |
$130.29 |
$274,458 |
D/D |
(2,093) |
17,705 |
|
-11% |
|
Maselli Alessandro |
President & COO |
|
2021-08-27 |
4 |
AS |
$130.29 |
$490,824 |
D/D |
(3,743) |
25,899 |
|
-11% |
|
Pravda Ricardo |
SVP & Chief HR Officer |
|
2021-08-27 |
4 |
AS |
$130.29 |
$90,742 |
D/D |
(692) |
12,835 |
|
-11% |
|
Fasman Steven L |
SVP & General Counsel |
|
2021-08-27 |
4 |
AS |
$130.29 |
$801,344 |
D/D |
(6,111) |
74,588 |
|
-11% |
|
Hopson Ricky |
VP, Chief Accounting Officer |
|
2021-08-27 |
4 |
AS |
$130.29 |
$192,894 |
D/D |
(1,471) |
19,398 |
|
-11% |
|
Arnold Jonathan |
Pres. Oral & Specialty Deliv. |
|
2021-08-27 |
4 |
AS |
$130.29 |
$59,271 |
D/D |
(452) |
46,745 |
|
-11% |
|
Schmidt Kay A |
SVP, Technical Operations |
|
2021-08-27 |
4 |
AS |
$130.29 |
$108,183 |
D/D |
(825) |
15,969 |
|
-11% |
|
Gunther Scott |
SVP, Quality & Reg. Affairs |
|
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
6,052 |
22,235 |
|
- |
|
Chiminski John R |
Chair & CEO |
|
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
105,418 |
274,360 |
|
- |
|
Grippo Michael J |
SVP, Strategy & Corp. Dev. |
|
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
4,984 |
16,255 |
|
- |
|
Gennadios Aristippos |
President Softgel & Oral Tech |
|
2021-08-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,008 |
59,743 |
|
- |
|
821 Records found
|
|
Page 10 of 33 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|